MERMAID-1: A phase III study of adjuvant durvalumab plus chemotherapy in resected NSCLC patients with MRD+ post-surgery Meeting Abstract
| Authors: | Peters, S.; Spigel, D.; Ahn, M.; Tsuboi, M.; Chaft, J.; Harpole, D.; Goss, G.; Barlesi, F.; Abbosh, C.; Poole, L.; May, R.; Dennis, P. A.; Swanton, C. |
| Abstract Title: | MERMAID-1: A phase III study of adjuvant durvalumab plus chemotherapy in resected NSCLC patients with MRD+ post-surgery |
| Meeting Title: | 2020 World Conference on Lung Cancer |
| Keywords: | adjuvant therapy; minimal residual disease; pd-l1 |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 28-31 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-03-01 |
| Start Page: | S258 |
| End Page: | S259 |
| Language: | English |
| ACCESSION: | WOS:000631349600363 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.01.376 |
| Notes: | Meeting Abstract: P03.03 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos |
